These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 32245967)
1. Pyrazinamide triggers degradation of its target aspartate decarboxylase. Gopal P; Sarathy JP; Yee M; Ragunathan P; Shin J; Bhushan S; Zhu J; Akopian T; Kandror O; Lim TK; Gengenbacher M; Lin Q; Rubin EJ; Grüber G; Dick T Nat Commun; 2020 Apr; 11(1):1661. PubMed ID: 32245967 [TBL] [Abstract][Full Text] [Related]
2. In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1. Gopal P; Tasneen R; Yee M; Lanoix JP; Sarathy J; Rasic G; Li L; Dartois V; Nuermberger E; Dick T ACS Infect Dis; 2017 Jul; 3(7):492-501. PubMed ID: 28271875 [TBL] [Abstract][Full Text] [Related]
3. Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD. Gopal P; Nartey W; Ragunathan P; Sarathy J; Kaya F; Yee M; Setzer C; Manimekalai MSS; Dartois V; Grüber G; Dick T ACS Infect Dis; 2017 Nov; 3(11):807-819. PubMed ID: 28991455 [TBL] [Abstract][Full Text] [Related]
4. Missense Mutations in the Unfoldase ClpC1 of the Caseinolytic Protease Complex Are Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis. Yee M; Gopal P; Dick T Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872068 [TBL] [Abstract][Full Text] [Related]
9. Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor Synthesis. Gopal P; Yee M; Sarathy J; Low JL; Sarathy JP; Kaya F; Dartois V; Gengenbacher M; Dick T ACS Infect Dis; 2016 Sep; 2(9):616-626. PubMed ID: 27759369 [TBL] [Abstract][Full Text] [Related]
10. Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis. Modlin SJ; Marbach T; Werngren J; Mansjö M; Hoffner SE; Valafar F Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722890 [TBL] [Abstract][Full Text] [Related]
11. Molecular principles behind pyrazinamide resistance due to mutations in panD gene in Mycobacterium tuberculosis. Pandey B; Grover S; Tyagi C; Goyal S; Jamal S; Singh A; Kaur J; Grover A Gene; 2016 Apr; 581(1):31-42. PubMed ID: 26784657 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide. Gopal P; Grüber G; Dartois V; Dick T Trends Pharmacol Sci; 2019 Dec; 40(12):930-940. PubMed ID: 31704175 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China. Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021 [TBL] [Abstract][Full Text] [Related]
14. Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis. Zhang Y; Zhang J; Cui P; Zhang Y; Zhang W Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584158 [TBL] [Abstract][Full Text] [Related]
15. Pyrazinoic Acid Inhibits a Bifunctional Enzyme in Mycobacterium tuberculosis. Njire M; Wang N; Wang B; Tan Y; Cai X; Liu Y; Mugweru J; Guo J; Hameed HMA; Tan S; Liu J; Yew WW; Nuermberger E; Lamichhane G; Liu J; Zhang T Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438933 [TBL] [Abstract][Full Text] [Related]
17. Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis: A Review and Update. Rajendran A; Palaniyandi K Curr Microbiol; 2022 Oct; 79(11):348. PubMed ID: 36209317 [TBL] [Abstract][Full Text] [Related]
18. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan. Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001 [TBL] [Abstract][Full Text] [Related]
19. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria. Singh P; Mishra AK; Malonia SK; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM J Commun Dis; 2006 Mar; 38(3):288-98. PubMed ID: 17373362 [TBL] [Abstract][Full Text] [Related]
20. Mutation in clpC1 encoding an ATP-dependent ATPase involved in protein degradation is associated with pyrazinamide resistance in Mycobacterium tuberculosis. Zhang S; Chen J; Shi W; Cui P; Zhang J; Cho S; Zhang W; Zhang Y Emerg Microbes Infect; 2017 Feb; 6(2):e8. PubMed ID: 28196969 [No Abstract] [Full Text] [Related] [Next] [New Search]